1. Home
  2. FNWB vs PLRX Comparison

FNWB vs PLRX Comparison

Compare FNWB & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Northwest Bancorp

FNWB

First Northwest Bancorp

HOLD

Current Price

$10.19

Market Cap

82.0M

Sector

Finance

ML Signal

HOLD

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.27

Market Cap

81.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWB
PLRX
Founded
1923
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.0M
81.1M
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
FNWB
PLRX
Price
$10.19
$1.27
Analyst Decision
Buy
Hold
Analyst Count
1
4
Target Price
$13.50
$2.67
AVG Volume (30 Days)
63.8K
571.1K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
0.68%
N/A
EPS Growth
36.00
29.97
EPS
N/A
N/A
Revenue
$176,000.00
N/A
Revenue This Year
$19.24
N/A
Revenue Next Year
$8.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.05
$1.09
52 Week High
$10.98
$1.95

Technical Indicators

Market Signals
Indicator
FNWB
PLRX
Relative Strength Index (RSI) 65.33 46.43
Support Level $9.26 $1.12
Resistance Level $10.33 $1.36
Average True Range (ATR) 0.33 0.07
MACD 0.08 -0.00
Stochastic Oscillator 84.96 50.00

Price Performance

Historical Comparison
FNWB
PLRX

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It offers various products and services, such as commercial business loans, multi-family real estate loans, auto and consumer loans, transaction accounts, savings and money market accounts, online banking services, etc., focused on the lending, deposit, and money movement needs of individuals, businesses and nonprofit organizations. The Group's operations are mainly focused on serving various communities in Washington State, U.S. Substantially all of its income is derived from a diverse base of commercial, mortgage, and consumer lending activities and investments.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: